Lusayan, Lhia B.

HRN: 22-57-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
CEFTRIAXONE 1G (VIAL)
07/13/2024
07/20/2024
IV
2 Grams
OD
CAP-HR, Presumptive TB
Waiting Final Action 
07/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/13/2024
07/13/2024
IV
4.5g
Loading Dose
CAP-HR; PTB
Waiting Final Action 
07/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/13/2024
07/19/2024
IV
2.25g
Q8
CAP-HR; PTB
Waiting Final Action 
07/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/13/2024
07/19/2024
IV
2.25g
Q6
CAP-MR; Presumptive PTB; Increased Frequency
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: